Remember meForgot password?
    Log in with Twitter
Press Release

Pre-Diabetes Test For Risk May Hold Key to Prevention - EZSCAN Medical Technology Comes to Canada

Canada NewsWire


TORONTO, Nov. 29, 2011 /CNW Telbec/ - Auto Control Medical, a privately owned Toronto-based company that distributes self-monitoring medical devices, is launching EZSCAN in Canada.  EZSCAN is a device designed to identify those at risk of developing Type 2 diabetes.  This non-invasive testing is painless and takes less than three minutes for the results.  "It was developed to identify prediabetes," said Robert Burgy, President of Auto Control Medical, "if you know you are at risk, then you can do something to try and prevent it from progressing to Type 2 diabetes."

According to the Canadian Diabetes Association, there are nine million Canadians living with diabetes or prediabetes.  Of  these, two million are unaware that they suffer from the disease.  Prediabetes is when blood glucose levels have started to rise but are not high enough to confirm a diabetes diagnosis.

"I have Type 2 diabetes myself, and as a person with diabetes bringing this technology to Canada means a great deal to me.  It's a huge step forward when at risk Canadians can be warned of the first signs of diabetes", said Burgy.

Developed in France by Impeto Medical, EZSCAN offers Healthcare Professionals a way to screen large numbers of people quickly and economically.  "There are a number of diseases that are spreading like epidemics," says Philippe Brunswick, Impeto Medical CEO, "and we are trying to find ways to economically screen for them."

EZSCAN uses sets of electrodes that measure the electrochemical reaction between these electrodes in contact with the patient's hands and feet and the chloride ions released by the sweat glands.  Leading researchers only recently realized that damage to small nerves began occurring before conventional blood tests would detect anything abnormal. Degeneration of the small nerve fibers reduces innervation of eccrine sweat glands.  It has just been approved for distribution by Health Canada and has been licensed for sale in Europe, China and Australia.

There are two types of diabetes:  Type I diabetes, usually manifests itself during childhood.  Type 2 diabetes, or often called adult onset diabetes, usually develops when a person is mature.

The onset of  Type 2 diabetes can be delayed or prevented through diet, physical exercise and weight loss.

"This is where EZSCAN comes into play," says Burgy, who will distribute the machines to medical offices, pharmacies and home health care stores.  This will enable the health care provider to participate fully in preventing or delaying the onset of Type 2 diabetes for their patients and customers.

"Simply put, EZSCAN can identify people who are at risk of developing diabetes and once you know you are at risk, you can do something to try and prevent it," says Burgy.

When it comes to both individual and mass screening for prediabetes, EZSCAN offers a number of critical advantages over the standard blood test.  It is painless and fasting is not required.  It can be done anytime and while blood tests take days for results, EZSCAN results are immediate, reliable and reproducible.  The results are delivered in a colour coded graph and are easily read.  A green measurement equates to "no risk", yellow means "moderate risk," orange identifies "high risk" and red is "a very high risk."

About Auto Control Medical Inc.

Auto Control Medical has been supplying Canadians with innovative health care products for over 20 years, from its offices in Mississauga (Ontario) and Pointe-Claire (Quebec). Its products include iTest glucose monitors, ExtendBar and LifeSource blood pressure monitors, Canada's leading brand, among others.


Image with caption: "EZ Scan in use (CNW Group/Auto Control Medical)". Image available at:

Image with caption: "Screen capture of EZ Scan (CNW Group/Vectorandshift) (CNW Group/Auto Control Medical)". Image available at: